Recent Presentations
BIO Investor Forum 2008
10/30/08
From the CEO
"We are dedicated to a targeted approach to treatment of heart disease in diabetic patients by testing for markers for patient risk stratification, as we advance our lead product candi- dates through clinical development. This represents a holistic and personalized medicine approach that we believe will ultimately prove successful and beneficial to the patient."
— Noah Berkowitz, M.D., Ph.D.